1 |
López-Cortés GI, Palacios-Pérez M, Hernández-Aguilar MM, Veledíaz HF, José MV. Human Coronavirus Cell Receptors Provide Challenging Therapeutic Targets. Vaccines (Basel) 2023;11. [PMID: 36680018 DOI: 10.3390/vaccines11010174] [Reference Citation Analysis]
|
2 |
Naeem M, Bano N, Manzoor S, Ahmad A, Munawar N, Razak SIA, Lee TY, Devaraj S, Hazafa A. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients. Biomolecules 2023;13. [PMID: 36671484 DOI: 10.3390/biom13010099] [Reference Citation Analysis]
|
3 |
Presti EL, Nuzzo D, Al Mahmeed W, Al-Rasadi K, Al-Alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Firenze A, Galia M, Goh SY, Janez A, Kalra S, Kapoor N, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Sahebkar A, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health. Biochim Biophys Acta Mol Basis Dis 2022;:166559. [PMID: 36174875 DOI: 10.1016/j.bbadis.2022.166559] [Reference Citation Analysis]
|
4 |
Aburto S, Cisterna M, Acuña J, Ruíz C, Viscardi S, Márquez JL, Villano I, Letelier P, Guzmán N. Obesity as a Risk Factor for Severe COVID-19 in Hospitalized Patients: Epidemiology and Potential Mechanisms. Healthcare 2022;10:1838. [DOI: 10.3390/healthcare10101838] [Reference Citation Analysis]
|
5 |
Widyahening IS, Vidiawati D, Pakasi TA, Soewondo P, Ahsan A. Noncommunicable diseases risk factors and the risk of COVID-19 among university employees in Indonesia. PLoS One 2022;17:e0263146. [PMID: 35666734 DOI: 10.1371/journal.pone.0263146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|